SAB Biotherapeutics Target Price

Explore SAB Biotherapeutics's target price with historical charts and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Share Price

$3.07

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-06-24	BarclaysEliana Merle	$13	323.5% upside
2026-05-20	Jefferies	$11	258.3% upside
2026-05-12	H.C. WainwrightEmily Bodnar	$10	225.7% upside
2026-01-07	UBSMichael Yee	$7	128% upside
2025-09-17	Leerink Partners	$7	128% upside
2024-06-07	Loop Capital MarketsKumaraguru Raja	$8	160.6% upside
2024-04-02	H.C. WainwrightEdward White	$6	95.4% upside
2022-08-11	Chardan Capital	$3	2.3% downside

SAB Biotherapeutics (SABS) FAQ

Stockcircle tracks target price for SAB Biotherapeutics (SABS), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for SAB Biotherapeutics's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main SABS overview so you can move from this figure to the surrounding analysis quickly.